Medpace Holdings Statistics

Total Valuation

FRA:01P has a market cap or net worth of EUR 13.27 billion. The enterprise value is 13.15 billion.

Market Cap	13.27B
Enterprise Value	13.15B

Important Dates

The next estimated earnings date is Monday, February 9, 2026.

Earnings Date	Feb 9, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	28.17M
Shares Outstanding	n/a
Shares Change (YoY)	-5.48%
Shares Change (QoQ)	-1.12%
Owned by Insiders (%)	19.47%
Owned by Institutions (%)	86.75%
Float	22.67M

Valuation Ratios

The trailing PE ratio is 35.97 and the forward PE ratio is 34.17.

PE Ratio	35.97
Forward PE	34.17
PS Ratio	6.60
PB Ratio	53.03
P/TBV Ratio	n/a
P/FCF Ratio	23.01
P/OCF Ratio	21.89
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 26.42, with an EV/FCF ratio of 22.80.

EV / Earnings	35.64
EV / Sales	6.49
EV / EBITDA	26.42
EV / EBIT	30.17
EV / FCF	22.80

Financial Position

The company has a current ratio of 0.57, with a Debt / Equity ratio of 0.49.

Current Ratio	0.57
Quick Ratio	0.51
Debt / Equity	0.49
Debt / EBITDA	0.25
Debt / FCF	0.21
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 73.70% and return on invested capital (ROIC) is 43.09%.

Return on Equity (ROE)	73.70%
Return on Assets (ROA)	16.52%
Return on Invested Capital (ROIC)	43.09%
Return on Capital Employed (ROCE)	108.09%
Revenue Per Employee	324,200
Profits Per Employee	59,513
Employee Count	5,900
Asset Turnover	1.23
Inventory Turnover	n/a

Taxes

In the past 12 months, FRA:01P has paid 73.65 million in taxes.

Income Tax	73.65M
Effective Tax Rate	16.64%

Stock Price Statistics

The stock price has increased by +41.59% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+41.59%
50-Day Moving Average	487.32
200-Day Moving Average	357.98
Relative Strength Index (RSI)	33.54
Average Volume (20 Days)	14

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.36

Income Statement

In the last 12 months, FRA:01P had revenue of EUR 2.01 billion and earned 368.98 million in profits. Earnings per share was 12.20.

Revenue	2.01B
Gross Profit	1.40B
Operating Income	432.15M
Pretax Income	442.71M
Net Income	368.98M
EBITDA	456.44M
EBIT	432.15M
Earnings Per Share (EPS)	12.20

Full Income Statement

Balance Sheet

The company has 243.20 million in cash and 122.71 million in debt, giving a net cash position of 120.50 million.

Cash & Cash Equivalents	243.20M
Total Debt	122.71M
Net Cash	120.50M
Net Cash Per Share	n/a
Equity (Book Value)	250.27M
Book Value Per Share	8.75
Working Capital	-465.89M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 606.19 million and capital expenditures -29.37 million, giving a free cash flow of 576.81 million.

Operating Cash Flow	606.19M
Capital Expenditures	-29.37M
Free Cash Flow	576.81M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 69.58%, with operating and profit margins of 21.50% and 18.36%.

Gross Margin	69.58%
Operating Margin	21.50%
Pretax Margin	22.02%
Profit Margin	18.36%
EBITDA Margin	22.71%
EBIT Margin	21.50%
FCF Margin	28.70%

Dividends & Yields

FRA:01P does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	5.48%
Shareholder Yield	5.48%
Earnings Yield	2.78%
FCF Yield	4.35%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:01P has an Altman Z-Score of 5.76 and a Piotroski F-Score of 6.

Altman Z-Score	5.76
Piotroski F-Score	6